Ian Schnadig Selected Research

PX-866

12/2016	A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma.
4/2015	A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer.
7/2014	A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian Schnadig Research Topics

Disease

3	Vomiting 01/2017 - 04/2016
3	Nausea 01/2017 - 04/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2020 - 12/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 12/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Systemic Mastocytosis 05/2016
1	Prostatic Neoplasms (Prostate Cancer) 08/2015
1	Glioblastoma (Glioblastoma Multiforme) 05/2015
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2015
1	Squamous Cell Carcinoma of Head and Neck 04/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014

Drug/Important Bio-Agent (IBA)

3	rolapitantIBA 01/2017 - 04/2016
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2016 - 07/2014
3	Phosphotransferases (Kinase)IBA 12/2016 - 07/2014
3	PX-866IBA 12/2016 - 07/2014
3	TOR Serine-Threonine KinasesIBA 12/2016 - 07/2014
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2016 - 07/2014
3	Docetaxel (Taxotere)FDA Link 08/2015 - 07/2014
2	NivolumabIBA 12/2020 - 12/2020
2	Neurokinin-1 Receptor AntagonistsIBA 01/2017 - 04/2016
1	AntiemeticsIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Substance PIBA 01/2017
1	Cetuximab (Erbitux)FDA Link 12/2016
1	Brentuximab VedotinIBA 05/2016
1	Immunoconjugates (Immunoconjugate)IBA 05/2016
1	Abiraterone AcetateIBA 08/2015
1	cabazitaxel FDA Link 08/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2015
1	Bevacizumab (Avastin)FDA Link 05/2015

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2017 - 04/2016
2	Therapeutics 01/2017 - 05/2016
1	Castration 08/2015